Cetera Investment Advisers’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-65,548
Closed -$6.66M 4862
2025
Q4
$6.66M Sell
65,548
-45,789
-41% -$3.68M 0.01% 1278
2025
Q3
$6.09M Buy
111,337
+6,331
+6% +$316K 0.01% 1284
2025
Q2
$5.58M Buy
105,006
+16,773
+19% +$852K 0.01% 1124
2025
Q1
$3.82M Buy
88,233
+5,596
+7% +$283K 0.01% 1283
2024
Q4
$4.64M Sell
82,637
-9,312
-10% -$579K 0.01% 1074
2024
Q3
$6.26M Sell
91,949
-71,892
-44% -$4.06M 0.01% 898
2024
Q2
$6.92M Buy
163,841
+56,174
+52% +$3.09M 0.02% 827
2024
Q1
$7.44M Buy
107,667
+54,632
+103% +$3.46M 0.02% 785
2023
Q4
$3.92M Buy
53,035
+7,536
+17% +$494K 0.03% 523
2023
Q3
$3.1M Buy
45,499
+1,219
+3% +$103K 0.03% 583
2023
Q2
$4.16M Buy
44,280
+345
+0.8% +$26.9K 0.04% 472
2023
Q1
$2.98M Sell
43,935
-3,668
-8% -$236K 0.03% 577
2022
Q4
$2.36M Buy
47,603
+21,705
+84% +$887K 0.02% 643
2022
Q3
$841K Sell
25,898
-876
-3% -$36.1K 0.02% 792
2022
Q2
$1.05M Sell
26,774
-733
-3% -$39.2K 0.02% 771
2022
Q1
$1.92M Buy
27,507
+1,732
+7% +$127K 0.03% 572
2021
Q4
$2.01M Buy
25,775
+4,093
+19% +$361K 0.03% 555
2021
Q3
$2.07M Buy
21,682
+1,260
+6% +$133K 0.03% 509
2021
Q2
$2.54M Buy
20,422
+12,443
+156% +$1.49M 0.04% 437
2021
Q1
$1.05M Sell
7,979
-10,040
-56% -$1.37M 0.02% 658
2020
Q4
$2.39M Buy
+18,019
New +$2.18M 0.05% 386

Other funds holding EXAS

Cetera Investment Advisers's EXAS Position: Q1 2026 in Review

Cetera Investment Advisers sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 65,548 shares — an estimated $6.66M sold.

Cetera Investment Advisers first reported a position in EXAS in Q4 2020 and held it in 21 quarters. The position peaked at $7.44M in Q1 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Cetera Investment Advisers reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Cetera Investment Advisers sold 65,548 Exact Sciences shares in Q1 2026, an estimated $6.66M.
  • Cetera Investment Advisers first reported a position in Exact Sciences in Q4 2020 and held it in 21 quarters.
  • Cetera Investment Advisers's Exact Sciences position peaked at $7.44M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.